This is a Validated Antibody Database (VAD) review about human NCR1, based on 53 published articles (read how Labome selects the articles), using NCR1 antibody in all methods. It is aimed to help Labome visitors find the most suited NCR1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
NCR1 synonym: CD335; LY94; NK-p46; NKP46

BioLegend
mouse monoclonal (9E2)
  • blocking or activating experiments; human; 10 ug/ml; loading ...; fig 2e
BioLegend NCR1 antibody (Biolegend, 9E2) was used in blocking or activating experiments on human samples at 10 ug/ml (fig 2e). BMC Biol (2021) ncbi
mouse monoclonal (9E2)
  • flow cytometry; human; loading ...; fig s1b
BioLegend NCR1 antibody (BioLegend, 331946) was used in flow cytometry on human samples (fig s1b). Immunity (2021) ncbi
mouse monoclonal (9E2)
  • flow cytometry; human; loading ...; fig s1
BioLegend NCR1 antibody (Biolegend, 9E2) was used in flow cytometry on human samples (fig s1). Front Immunol (2020) ncbi
mouse monoclonal (9E2)
  • other; mouse
BioLegend NCR1 antibody (BioLegend, 9E2) was used in other on mouse samples . Nat Commun (2020) ncbi
mouse monoclonal (9E2)
  • flow cytometry; human; loading ...
BioLegend NCR1 antibody (BioLegend, 9E2) was used in flow cytometry on human samples . elife (2020) ncbi
mouse monoclonal (9E2)
  • flow cytometry; human; loading ...; fig 3c
BioLegend NCR1 antibody (Biolegend, 331912) was used in flow cytometry on human samples (fig 3c). Cell Rep (2019) ncbi
mouse monoclonal (9E2)
  • flow cytometry; human; loading ...
BioLegend NCR1 antibody (Biolegend, 9E2) was used in flow cytometry on human samples . Front Immunol (2019) ncbi
mouse monoclonal (9E2)
  • flow cytometry; human; loading ...; fig 2a
BioLegend NCR1 antibody (BioLegend, 331926) was used in flow cytometry on human samples (fig 2a). Cell (2019) ncbi
mouse monoclonal (9E2)
  • flow cytometry; human; loading ...; fig 1a
BioLegend NCR1 antibody (BioLegend, 331915) was used in flow cytometry on human samples (fig 1a). Eur J Immunol (2018) ncbi
mouse monoclonal (9E2)
  • flow cytometry; human; fig 1b
In order to study the involvement of Notch signaling in NK cell lineage determination, BioLegend NCR1 antibody (biolegend, 9E2) was used in flow cytometry on human samples (fig 1b). J Immunol (2017) ncbi
mouse monoclonal (9E2)
  • flow cytometry; human; loading ...; fig s4a
In order to map the lineage of human dendritic cells, BioLegend NCR1 antibody (BioLegend, 9E2) was used in flow cytometry on human samples (fig s4a). Science (2017) ncbi
mouse monoclonal (9E2)
  • flow cytometry; human; 1:50; loading ...; fig 2a
In order to measure CD11d expression on lymphocyte subsets using flow cytometry, BioLegend NCR1 antibody (BioLegend, 9E2) was used in flow cytometry on human samples at 1:50 (fig 2a). J Leukoc Biol (2017) ncbi
mouse monoclonal (9E2)
  • flow cytometry; human; loading ...; fig 1b
In order to ask if CD2 is involved in the response of adaptive natural killer cells to HCMV, BioLegend NCR1 antibody (BioLegend, 9E2) was used in flow cytometry on human samples (fig 1b). Eur J Immunol (2016) ncbi
mouse monoclonal (9E2)
  • flow cytometry; human; fig 1a
In order to assess the effects of platelet-derived ectosomes on natural killer cells, BioLegend NCR1 antibody (BioLegend, 9E2) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (9E2)
  • flow cytometry; human; loading ...; fig 5b
BioLegend NCR1 antibody (Biolegend, 9E2) was used in flow cytometry on human samples (fig 5b). J Biol Chem (2016) ncbi
mouse monoclonal (9E2)
  • flow cytometry; human; fig s2
In order to report the phase I trial results of CDX-301, BioLegend NCR1 antibody (Biolegend, 9E2) was used in flow cytometry on human samples (fig s2). Bone Marrow Transplant (2015) ncbi
mouse monoclonal (9E2)
  • flow cytometry; human
BioLegend NCR1 antibody (Biolegend, 331909) was used in flow cytometry on human samples . Scand J Immunol (2015) ncbi
mouse monoclonal (9E2)
  • flow cytometry; human
BioLegend NCR1 antibody (BioLegend, 9E2) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (9E2)
  • flow cytometry; human; fig 1
BioLegend NCR1 antibody (BioLegend, 9E2) was used in flow cytometry on human samples (fig 1). J Immunol (2015) ncbi
mouse monoclonal (9E2)
  • flow cytometry; human; fig 2
BioLegend NCR1 antibody (Biolegend, 9E2) was used in flow cytometry on human samples (fig 2). Eur J Immunol (2015) ncbi
mouse monoclonal (9E2)
  • flow cytometry; human
BioLegend NCR1 antibody (BioLegend, 9E2) was used in flow cytometry on human samples . Immunol Lett (2014) ncbi
mouse monoclonal (9E2)
  • flow cytometry; human; tbl 1
In order to study the effect of innate lymphoid cells on B cells, BioLegend NCR1 antibody (Biolegend, 9E2) was used in flow cytometry on human samples (tbl 1). Nat Immunol (2014) ncbi
R&D Systems
domestic goat polyclonal
  • immunohistochemistry; mouse; loading ...; fig 4d
R&D Systems NCR1 antibody (R&D System, AF2225) was used in immunohistochemistry on mouse samples (fig 4d). Nat Commun (2021) ncbi
mouse monoclonal (195314)
  • immunohistochemistry; human; 10 ug/ml; loading ...; fig s2a8
R&D Systems NCR1 antibody (R&D systems, 195314) was used in immunohistochemistry on human samples at 10 ug/ml (fig s2a8). Neuropathol Appl Neurobiol (2021) ncbi
Miltenyi Biotec
human monoclonal (REA808)
  • flow cytometry; human; 1:50; loading ...; fig e4f
Miltenyi Biotec NCR1 antibody (Miltenyi, 130-112-276) was used in flow cytometry on human samples at 1:50 (fig e4f). Nature (2019) ncbi
human monoclonal (REA808)
  • flow cytometry; human; loading ...; fig 4c
Miltenyi Biotec NCR1 antibody (Miltenyi Biotec, 130-112-122) was used in flow cytometry on human samples (fig 4c). Front Immunol (2018) ncbi
mouse monoclonal (9E2)
  • flow cytometry; human; loading ...; fig 7b
In order to determine the contribution of CD16 positive monocytes to antibody-dependent cellular cytotoxicity, Miltenyi Biotec NCR1 antibody (Miltenyi Biotec, 9E2) was used in flow cytometry on human samples (fig 7b). Sci Rep (2016) ncbi
Invitrogen
mouse monoclonal (9E2)
  • flow cytometry; human; loading ...; fig s2
Invitrogen NCR1 antibody (eBioscience, 17-3359-42) was used in flow cytometry on human samples (fig s2). BMC Cancer (2019) ncbi
mouse monoclonal (9E2)
  • flow cytometry; human
Invitrogen NCR1 antibody (eBioscience, 9E2) was used in flow cytometry on human samples . Cell Immunol (2014) ncbi
Santa Cruz Biotechnology
mouse monoclonal (9E2)
  • immunocytochemistry; zebrafish ; fig 5
Santa Cruz Biotechnology NCR1 antibody (Santa Cruz, sc-53599) was used in immunocytochemistry on zebrafish samples (fig 5). Neoplasia (2016) ncbi
Abcam
mouse monoclonal (N1d9)
  • immunohistochemistry - paraffin section; human; loading ...; fig 6a
Abcam NCR1 antibody (Abcam, ab14823) was used in immunohistochemistry - paraffin section on human samples (fig 6a). Int J Cancer (2018) ncbi
Beckman Coulter
mouse monoclonal (BAB281)
  • flow cytometry; human; loading ...; fig s1b
Beckman Coulter NCR1 antibody (Beckman Coulter, IM3711) was used in flow cytometry on human samples (fig s1b). Cell (2019) ncbi
mouse monoclonal (BAB281)
  • flow cytometry; human; loading ...; fig 2a
Beckman Coulter NCR1 antibody (Beckman Coulter, BAB281) was used in flow cytometry on human samples (fig 2a). Front Immunol (2019) ncbi
mouse monoclonal (BAB281)
  • flow cytometry; human; loading ...; fig s2a
Beckman Coulter NCR1 antibody (Beckman Coulter, BAB281) was used in flow cytometry on human samples (fig s2a). J Infect Dis (2019) ncbi
mouse monoclonal (BAB281)
  • flow cytometry; rhesus macaque; loading ...; fig 1b
Beckman Coulter NCR1 antibody (Beckman Coulter, BAB281) was used in flow cytometry on rhesus macaque samples (fig 1b). AIDS (2018) ncbi
mouse monoclonal (BAB281)
  • flow cytometry; mouse; fig 1e
Beckman Coulter NCR1 antibody (Beckman Coulter, IM3711) was used in flow cytometry on mouse samples (fig 1e). J Virol (2017) ncbi
mouse monoclonal (BAB281)
  • flow cytometry; human; loading ...; fig 3b
Beckman Coulter NCR1 antibody (Beckman Coulter, BAB281) was used in flow cytometry on human samples (fig 3b). Immun Ageing (2017) ncbi
mouse monoclonal (BAB281)
  • flow cytometry; human; loading ...; fig 2a
Beckman Coulter NCR1 antibody (Beckman Coulter, BAB281) was used in flow cytometry on human samples (fig 2a). Oncotarget (2016) ncbi
mouse monoclonal (BAB281)
  • flow cytometry; common marmoset; loading ...; fig 6a
Beckman Coulter NCR1 antibody (Immunotech, BAB281) was used in flow cytometry on common marmoset samples (fig 6a). J Virol (2016) ncbi
mouse monoclonal (BAB281)
  • flow cytometry; human
Beckman Coulter NCR1 antibody (Beckman, BAB281) was used in flow cytometry on human samples . Clin Cancer Res (2014) ncbi
BD Biosciences
mouse monoclonal (9E2/NKp46)
  • flow cytometry; human; loading ...; fig 5a
BD Biosciences NCR1 antibody (BD Pharmingen, 9E2) was used in flow cytometry on human samples (fig 5a). Front Immunol (2019) ncbi
mouse monoclonal (9E2/NKp46)
  • immunohistochemistry - frozen section; human; loading ...; fig 4c
BD Biosciences NCR1 antibody (BD, 557911) was used in immunohistochemistry - frozen section on human samples (fig 4c). Cell (2018) ncbi
mouse monoclonal (9E2/NKp46)
  • flow cytometry; human; loading ...; fig s1f
BD Biosciences NCR1 antibody (BD Biosciences, 7C9) was used in flow cytometry on human samples (fig s1f). J Clin Invest (2018) ncbi
mouse monoclonal (9E2/NKp46)
  • flow cytometry; human; loading ...
In order to investigate the role of natural killer cells to lymphangioleiomyomatosis pathogenesis, BD Biosciences NCR1 antibody (BD Biosciences, 9E2/NKp46) was used in flow cytometry on human samples . JCI Insight (2016) ncbi
mouse monoclonal (9E2/NKp46)
  • flow cytometry; human; loading ...; fig 1a
In order to discuss targeting CD123 to treat systemic lupus erythematosus, BD Biosciences NCR1 antibody (BD Biosciences, 558051) was used in flow cytometry on human samples (fig 1a). JCI Insight (2016) ncbi
mouse monoclonal (9E2/NKp46)
  • flow cytometry; human; loading ...; fig s1
BD Biosciences NCR1 antibody (BD Biosciences, 9E2) was used in flow cytometry on human samples (fig s1). J Clin Invest (2016) ncbi
mouse monoclonal (9E2/NKp46)
  • flow cytometry; human; loading ...; fig 1e
BD Biosciences NCR1 antibody (BD Biosciences, 9E2/NKp46) was used in flow cytometry on human samples (fig 1e). J Immunol (2016) ncbi
mouse monoclonal (9E2/NKp46)
  • flow cytometry; human; 1:100; fig 2
In order to elucidate the marked reduction of Nkp44/Nkp46-double positive natural killer cells by celiac disease-related inflammation, BD Biosciences NCR1 antibody (Becton Dickinson, 9E2/Nkp46) was used in flow cytometry on human samples at 1:100 (fig 2). PLoS ONE (2016) ncbi
mouse monoclonal (9E2/NKp46)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences NCR1 antibody (BD, 557991) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (9E2/NKp46)
  • flow cytometry; human
BD Biosciences NCR1 antibody (BD Pharmingen, 558051) was used in flow cytometry on human samples . Am J Reprod Immunol (2015) ncbi
mouse monoclonal (9E2/NKp46)
  • flow cytometry; human; fig 6
BD Biosciences NCR1 antibody (BD Bioscience, 557991) was used in flow cytometry on human samples (fig 6). PLoS ONE (2015) ncbi
mouse monoclonal (9E2/NKp46)
  • flow cytometry; human
BD Biosciences NCR1 antibody (BD Biosciences, 9E2/NKp46) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (9E2/NKp46)
  • flow cytometry; human
In order to study NK function in solid tumors, BD Biosciences NCR1 antibody (BD Biosciences, 9E2) was used in flow cytometry on human samples . Int J Cancer (2014) ncbi
Articles Reviewed
  1. Xu B, Tian L, Chen J, Wang J, Ma R, Dong W, et al. An oncolytic virus expressing a full-length antibody enhances antitumor innate immune response to glioblastoma. Nat Commun. 2021;12:5908 pubmed publisher
  2. Zhu Y, Xie J, Shi J. Rac1/ROCK-driven membrane dynamics promote natural killer cell cytotoxicity via granzyme-induced necroptosis. BMC Biol. 2021;19:140 pubmed publisher
  3. Zimmer T, Broekaart D, Luinenburg M, Mijnsbergen C, Anink J, Sim N, et al. Balloon cells promote immune system activation in focal cortical dysplasia type 2b. Neuropathol Appl Neurobiol. 2021;47:826-839 pubmed publisher
  4. Szabo P, Dogra P, Gray J, Wells S, Connors T, Weisberg S, et al. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity. 2021;54:797-814.e6 pubmed publisher
  5. Katano I, Ito R, Kawai K, Takahashi T. Improved Detection of in vivo Human NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Using a Novel NOG-FcγR-Deficient Human IL-15 Transgenic Mouse. Front Immunol. 2020;11:532684 pubmed publisher
  6. Tseng H, Xiong W, Badeti S, Yang Y, Ma M, Liu T, et al. Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma. Nat Commun. 2020;11:4810 pubmed publisher
  7. Hood S, Cosma G, Foulds G, Johnson C, Reeder S, McArdle S, et al. Identifying prostate cancer and its clinical risk in asymptomatic men using machine learning of high dimensional peripheral blood flow cytometric natural killer cell subset phenotyping data. elife. 2020;9: pubmed publisher
  8. Leylek R, Alcántara Hernández M, Lanzar Z, Lüdtke A, Perez O, Reizis B, et al. Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Rep. 2019;29:3736-3750.e8 pubmed publisher
  9. Ramachandran P, Dobie R, Wilson Kanamori J, Dora E, Henderson B, Luu N, et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature. 2019;575:512-518 pubmed publisher
  10. Sanz Ortega L, Rojas J, Portilla Y, Pérez Yagüe S, Barber D. Magnetic Nanoparticles Attached to the NK Cell Surface for Tumor Targeting in Adoptive Transfer Therapies Does Not Affect Cellular Effector Functions. Front Immunol. 2019;10:2073 pubmed publisher
  11. Choi J, Lee E, Kim S, Park S, Oh S, Kang J, et al. Cytotoxic effects of ex vivo-expanded natural killer cell-enriched lymphocytes (MYJ1633) against liver cancer. BMC Cancer. 2019;19:817 pubmed publisher
  12. Gauthier L, Morel A, Anceriz N, Rossi B, Blanchard Alvarez A, Grondin G, et al. Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity. Cell. 2019;177:1701-1713.e16 pubmed publisher
  13. Ingegnere T, Mariotti F, Pelosi A, Quintarelli C, De Angelis B, Tumino N, et al. Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing. Front Immunol. 2019;10:957 pubmed publisher
  14. Lim S, Kim J, Jeon S, Shin M, Kwon J, Kim T, et al. Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients. Front Immunol. 2019;10:496 pubmed publisher
  15. Mayassi T, Ladell K, Gudjonson H, McLaren J, Shaw D, Tran M, et al. Chronic Inflammation Permanently Reshapes Tissue-Resident Immunity in Celiac Disease. Cell. 2019;176:967-981.e19 pubmed publisher
  16. Andre P, Denis C, Soulas C, Bourbon Caillet C, Lopez J, Arnoux T, et al. Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells. Cell. 2018;175:1731-1743.e13 pubmed publisher
  17. van Erp E, Feyaerts D, Duijst M, Mulder H, Wicht O, Luytjes W, et al. Respiratory Syncytial Virus Infects Primary Neonatal and Adult Natural Killer Cells and Affects Their Antiviral Effector Function. J Infect Dis. 2019;219:723-733 pubmed publisher
  18. Keszei M, Record J, Kritikou J, Wurzer H, Geyer C, Thiemann M, et al. Constitutive activation of WASp in X-linked neutropenia renders neutrophils hyperactive. J Clin Invest. 2018;128:4115-4131 pubmed publisher
  19. Voigt J, Malone D, Dias J, Leeansyah E, Björkström N, Ljunggren H, et al. Proteome analysis of human CD56neg NK cells reveals a homogeneous phenotype surprisingly similar to CD56dim NK cells. Eur J Immunol. 2018;48:1456-1469 pubmed publisher
  20. Capuano C, Battella S, Pighi C, Franchitti L, Turriziani O, Morrone S, et al. Tumor-Targeting Anti-CD20 Antibodies Mediate In Vitro Expansion of Memory Natural Killer Cells: Impact of CD16 Affinity Ligation Conditions and In Vivo Priming. Front Immunol. 2018;9:1031 pubmed publisher
  21. Manickam C, Nwanze C, Ram D, Shah S, Smith S, Jones R, et al. Progressive lentivirus infection induces natural killer cell receptor-expressing B cells in the gastrointestinal tract. AIDS. 2018;32:1571-1578 pubmed publisher
  22. Qu S, Xue H, Dong X, Lin D, Wu R, Nabavi N, et al. Aneustat (OMN54) has aerobic glycolysis-inhibitory activity and also immunomodulatory activity as indicated by a first-generation PDX prostate cancer model. Int J Cancer. 2018;143:419-429 pubmed publisher
  23. Kyoizumi S, Kubo Y, Kajimura J, Yoshida K, Hayashi T, Nakachi K, et al. Fate Decision Between Group 3 Innate Lymphoid and Conventional NK Cell Lineages by Notch Signaling in Human Circulating Hematopoietic Progenitors. J Immunol. 2017;199:2777-2793 pubmed publisher
  24. Bar On Y, Charpak Amikam Y, Glasner A, Isaacson B, Duev Cohen A, Tsukerman P, et al. NKp46 Recognizes the Sigma1 Protein of Reovirus: Implications for Reovirus-Based Cancer Therapy. J Virol. 2017;91: pubmed publisher
  25. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed publisher
  26. van der Geest K, Wang Q, Eijsvogels T, Koenen H, Joosten I, Brouwer E, et al. Changes in peripheral immune cell numbers and functions in octogenarian walkers - an acute exercise study. Immun Ageing. 2017;14:5 pubmed publisher
  27. Siegers G, Barreira C, Postovit L, Dekaban G. CD11d ?2 integrin expression on human NK, B, and ?? T cells. J Leukoc Biol. 2017;101:1029-1035 pubmed publisher
  28. Osterburg A, Nelson R, Yaniv B, Foot R, Donica W, Nashu M, et al. NK cell activating receptor ligand expression in lymphangioleiomyomatosis is associated with lung function decline. JCI Insight. 2016;1:e87270 pubmed publisher
  29. Oon S, Huynh H, Tai T, Ng M, Monaghan K, Biondo M, et al. A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus. JCI Insight. 2016;1:e86131 pubmed publisher
  30. Yeap W, Wong K, Shimasaki N, Teo E, Quek J, Yong H, et al. CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes. Sci Rep. 2016;6:34310 pubmed publisher
  31. Landtwing V, Raykova A, Pezzino G, Beziat V, Marcenaro E, Graf C, et al. Cognate HLA absence in trans diminishes human NK cell education. J Clin Invest. 2016;126:3772-3782 pubmed publisher
  32. Jung I, Chung Y, Jung D, Kim Y, Kim D, Kim K, et al. Impaired Lymphocytes Development and Xenotransplantation of Gastrointestinal Tumor Cells in Prkdc-Null SCID Zebrafish Model. Neoplasia. 2016;18:468-79 pubmed publisher
  33. Manzini C, Venè R, Cossu I, Gualco M, Zupo S, Dono M, et al. Cytokines can counteract the inhibitory effect of MEK-i on NK-cell function. Oncotarget. 2016;7:60858-60871 pubmed publisher
  34. Manickam C, Rajakumar P, Wachtman L, Kramer J, Martinot A, Varner V, et al. Acute Liver Damage Associated with Innate Immune Activation in a Small Nonhuman Primate Model of Hepacivirus Infection. J Virol. 2016;90:9153-62 pubmed publisher
  35. Rölle A, Halenius A, Ewen E, Cerwenka A, Hengel H, Momburg F. CD2-CD58 interactions are pivotal for the activation and function of adaptive natural killer cells in human cytomegalovirus infection. Eur J Immunol. 2016;46:2420-2425 pubmed publisher
  36. Sadallah S, Schmied L, Eken C, Charoudeh H, Amicarella F, Schifferli J. Platelet-Derived Ectosomes Reduce NK Cell Function. J Immunol. 2016;197:1663-71 pubmed publisher
  37. Zanetti S, Ziblat A, Torres N, Zwirner N, Bouzat C. Expression and Functional Role of ?7 Nicotinic Receptor in Human Cytokine-stimulated Natural Killer (NK) Cells. J Biol Chem. 2016;291:16541-52 pubmed publisher
  38. Loyon R, Picard E, Mauvais O, Queiroz L, Mougey V, Pallandre J, et al. IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner. J Immunol. 2016;197:85-96 pubmed publisher
  39. Marafini I, Monteleone I, Di Fusco D, Sedda S, Cupi M, Fina D, et al. Celiac Disease-Related Inflammation Is Marked by Reduction of Nkp44/Nkp46-Double Positive Natural Killer Cells. PLoS ONE. 2016;11:e0155103 pubmed publisher
  40. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  41. Djurisic S, Skibsted L, Hviid T. A Phenotypic Analysis of Regulatory T Cells and Uterine NK Cells from First Trimester Pregnancies and Associations with HLA-G. Am J Reprod Immunol. 2015;74:427-44 pubmed publisher
  42. Zou Y, Bao J, Pan X, Lu Y, Liao S, Wang X, et al. NKP30-B7-H6 Interaction Aggravates Hepatocyte Damage through Up-Regulation of Interleukin-32 Expression in Hepatitis B Virus-Related Acute-On-Chronic Liver Failure. PLoS ONE. 2015;10:e0134568 pubmed publisher
  43. Anandasabapathy N, Breton G, Hurley A, Caskey M, Trumpfheller C, Sarma P, et al. Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers. Bone Marrow Transplant. 2015;50:924-30 pubmed publisher
  44. Dyring Andersen B, Bonefeld C, Bzorek M, Løvendorf M, Lauritsen J, Skov L, et al. The Vitamin D Analogue Calcipotriol Reduces the Frequency of CD8+ IL-17+ T Cells in Psoriasis Lesions. Scand J Immunol. 2015;82:84-91 pubmed publisher
  45. Zhou J, Amran F, Kramski M, Angelovich T, Elliott J, Hearps A, et al. An NK Cell Population Lacking FcRγ Is Expanded in Chronically Infected HIV Patients. J Immunol. 2015;194:4688-97 pubmed publisher
  46. Strick Marchand H, Dusséaux M, Darche S, Huntington N, Legrand N, Masse Ranson G, et al. A novel mouse model for stable engraftment of a human immune system and human hepatocytes. PLoS ONE. 2015;10:e0119820 pubmed publisher
  47. Marquardt N, Béziat V, Nyström S, Hengst J, Ivarsson M, Kekäläinen E, et al. Cutting edge: identification and characterization of human intrahepatic CD49a+ NK cells. J Immunol. 2015;194:2467-71 pubmed publisher
  48. Ziblat A, Domaica C, Spallanzani R, Iraolagoitia X, Rossi L, Avila D, et al. IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness. Eur J Immunol. 2015;45:192-202 pubmed publisher
  49. Sullivan E, Jeha S, Kang G, Cheng C, Rooney B, Holladay M, et al. NK cell genotype and phenotype at diagnosis of acute lymphoblastic leukemia correlate with postinduction residual disease. Clin Cancer Res. 2014;20:5986-94 pubmed publisher
  50. Jiang B, Wu X, Li X, Yang X, Zhou Y, Yan H, et al. Expansion of NK cells by engineered K562 cells co-expressing 4-1BBL and mMICA, combined with soluble IL-21. Cell Immunol. 2014;290:10-20 pubmed publisher
  51. Kobayashi E, Motoi S, Sugiura M, Kajikawa M, Kojima S, Kohroki J, et al. Antibody-dependent cellular cytotoxicity and cytokine/chemokine secretion by KHYG-1 cells stably expressing Fc?RIIIA. Immunol Lett. 2014;161:59-64 pubmed publisher
  52. Prinz P, Mendler A, Brech D, Masouris I, Oberneder R, Noessner E. NK-cell dysfunction in human renal carcinoma reveals diacylglycerol kinase as key regulator and target for therapeutic intervention. Int J Cancer. 2014;135:1832-41 pubmed publisher
  53. Magri G, Miyajima M, Bascones S, Mortha A, Puga I, Cassis L, et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol. 2014;15:354-364 pubmed publisher